OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
OpenAI's Operator is a first-of-its-kind tool that uses a remote browser to mimic human actions, allowing users to delegate tasks.
We recently published a list of 10 AI Stocks Investors are Watching Closely. In this article, we are going to take a look at ...
The media and other bad actors are on a mission to drive a wedge between President Donald J. Trump and Elon Musk who has helped to supercharge […] ...
OpenAI is putting its focus on AI infrastructure with Stargate at a time when rivals like China's DeepSeek are closing the ...
We recently published a list of 10 AI Stocks Investors are Watching Closely. In this article, we are going to take a look at ...
Cathie Wood and her Ark Invest funds sold Oklo — the nuclear power startup backed by OpenAI head Sam Altman — and purchased ...